Propafenone analogue with additional H‐bond acceptor group shows increased inhibitory activity on P‐glycoprotein

Author(s)
Anna Cseke, Theresa Schwarz, Sankalp Jain, Simon Decker, Kerstin Vogl, Ernst Urban, Gerhard Ecker
Abstract

P‐glycoprotein (P‐gp) is an ATP‐dependent efflux pump that has a marked impact on the absorption, distribution, and excretion of therapeutic drugs. As P‐gp inhibition can result in drug–drug interactions and altered drug bioavailability, identifying molecular properties that are linked to inhibition is of great interest in drug development. In this study, we combined chemical synthesis, in vitro testing, quantitative structure–activity relationship analysis, and docking studies to investigate the role of hydrogen bond (H‐bond) donor/acceptor properties in transporter–ligand interaction. In a previous work, it has been shown that propafenone analogs with a 4‐hydroxy‐4‐piperidine moiety exhibit a generally 10‐fold higher P‐gp inhibitory activity than expected based on their lipophilicity. Here, we specifically expanded the data set by introducing substituents at position 4 of the 4‐phenylpiperidine moiety to assess the importance of H‐bond donor/acceptor features in this region. The results suggest that indeed an H‐bond acceptor, such as hydroxy and methoxy, increases the affinity by forming a H‐bond with Tyr310.

Organisation(s)
External organisation(s)
National Institutes of Health (NIH), Universität Wien
Journal
Archiv der Pharmazie
Volume
353
No. of pages
11
ISSN
0365-6233
DOI
https://doi.org/10.1002/ardp.201900269
Publication date
03-2020
Peer reviewed
Yes
Austrian Fields of Science 2012
104015 Organic chemistry, 102004 Bioinformatics, 106002 Biochemistry, 301207 Pharmaceutical chemistry
Keywords
ASJC Scopus subject areas
Drug Discovery, Pharmaceutical Science
Portal url
https://ucris.univie.ac.at/portal/en/publications/propafenone-analogue-with-additional-hbond-acceptor-group-shows-increased-inhibitory-activity-on-pglycoprotein(f6b85fdc-9ed8-41cb-bcee-2dc628b50bae).html